Is Toxoplasma gondii a potential risk factor for Alzheimer's disease? A systematic review and meta-analysis.

[1]  R. Alizadeh-Navaei,et al.  The potential risk of toxoplasmosis for traffic accidents: A systematic review and meta-analysis. , 2018, Experimental parasitology.

[2]  A. Daryani,et al.  Toxoplasmosis seroprevalence in rheumatoid arthritis patients: A systematic review and meta-analysis , 2018, PLoS neglected tropical diseases.

[3]  L. Hood,et al.  Toxoplasma Modulates Signature Pathways of Human Epilepsy, Neurodegeneration & Cancer , 2017, Scientific Reports.

[4]  J. Soares,et al.  Is there any association between Toxoplasma gondii infection and bipolar disorder? A systematic review and meta-analysis. , 2017, Journal of affective disorders.

[5]  J. Flegr,et al.  Toxoplasma-Infected Subjects Report an Obsessive-Compulsive Disorder Diagnosis More Often and Score Higher in Obsessive-Compulsive Inventory , 2017, European Psychiatry.

[6]  Wafaa M. Zaki,et al.  SEROPREVALENCE OF TOXOPLASMA GONDII INFECTION AND ITS AS- SOCIATED RISK FACTORS IN NEUROPSYCHIATRIC PATIENTS IN JAZAN PROVINCE, SAUDI ARABIA. , 2016, Journal of the Egyptian Society of Parasitology.

[7]  J. Flegr,et al.  Impaired health status and increased incidence of diseases in Toxoplasma-seropositive subjects – an explorative cross-sectional study , 2016, Parasitology.

[8]  M. Nasiri,et al.  Molecular detection of Toxoplasma gondii in snakes. , 2016, Experimental parasitology.

[9]  A. Keyhani,et al.  Toxoplasma gondii Infection Potentiates Cognitive Impairments of Alzheimer's Disease in the BALB/c Mice , 2016, Journal of Parasitology.

[10]  M. Birjandi,et al.  Seroprevalence of Toxoplasma gondii Infection in Patients with Alzheimer’s Disease , 2016 .

[11]  H. Fricker-Hidalgo,et al.  Relevance of and New Developments in Serology for Toxoplasmosis. , 2016, Trends in parasitology.

[12]  H. Sadeghi-Bazargani,et al.  Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? , 2016, Parasitology Research.

[13]  J. Kauwe,et al.  Seroprevalence and Serointensity of Latent Toxoplasma gondii in a Sample of Elderly Adults With and Without Alzheimer Disease , 2016, Alzheimer disease and associated disorders.

[14]  J. Saki,et al.  Seroprevalence of toxoplasmosis in diabetic pregnant women in southwestern of Iran , 2016, Journal of Parasitic Diseases.

[15]  Meng Zhang,et al.  A study on the association between infectious burden and Alzheimer's disease , 2015, European journal of neurology.

[16]  M. Leboyer,et al.  Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta‐analysis , 2015, Acta psychiatrica Scandinavica.

[17]  W. Dong,et al.  Seroprevalence and associated risk factors of Toxoplasma gondii infection in psychiatric patients: a case-control study in eastern China , 2015, Epidemiology and Infection.

[18]  D. Bhalla,et al.  Toxoplasmosis and Epilepsy — Systematic Review and Meta Analysis , 2015, PLoS neglected tropical diseases.

[19]  C. Carter.  Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders , 2013, Journal of pathogens.

[20]  G. Quattrocchi,et al.  Toxocariasis and Epilepsy: Systematic Review and Meta-Analysis , 2012, PLoS neglected tropical diseases.

[21]  F. Robert-Gangneux,et al.  Epidemiology of and Diagnostic Strategies for Toxoplasmosis , 2012, Clinical Microbiology Reviews.

[22]  Y. Suh,et al.  Toxoplasma gondii Infection in the Brain Inhibits Neuronal Degeneration and Learning and Memory Impairments in a Murine Model of Alzheimer's Disease , 2012, PloS one.

[23]  M. Yaman,et al.  Could Toxoplasma gondii Have any Role in Alzheimer Disease? , 2011, Alzheimer disease and associated disorders.

[24]  A. Stang.  Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses , 2010, European Journal of Epidemiology.

[25]  D. Moher,et al.  Reprint--preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2009, Physical therapy.

[26]  N. Inestrosa,et al.  Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice. , 2008, Chemico-biological interactions.

[27]  J. Dubey,et al.  Toxoplasma gondii infection in humans and animals in the United States. , 2008, International journal for parasitology.

[28]  P. Moreira,et al.  Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease. , 2008, Free radical biology & medicine.

[29]  Der-Zen Liu,et al.  Hemorheological Mechanisms in Alzheimer's Disease , 2007, Microcirculation.

[30]  O. Liesenfeld,et al.  Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city , 2006, BMC infectious diseases.

[31]  D. Hill,et al.  Biology and epidemiology of Toxoplasma gondii in man and animals , 2005, Animal Health Research Reviews.

[32]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[33]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[34]  A. Dalimi,et al.  Latent Toxoplasmosis and Human , 2012, Iranian journal of parasitology.

[35]  J. Webster.  Dubey, J.P. Toxoplasmosis of Animals and Humans , 2010, Parasites & Vectors.

[36]  M VALENTINCIC,et al.  [Toxoplasma gondii]. , 1953, Zdravstveni vestnik.